Thyroid Gland
Hyperthyroidism
Deependra Shrestha
Clinical Scenario
• A 39-year-old female presents to the clinic for a routine health maintenance
exam.
• She reports that she is feeling nervous and anxious all the time with frequent
palpitations.
• On further questioning she reports having diarrhea and has been losing weight.
• She has also noticed a change in hair and fingernail growth and frequently feels
warm while others are cold or comfortable.
• She denies any history of depression or anxiety disorder and is not taking any
medications.
• On examination, her heart rate is 110 beats per minute. She has a slight tremor
and has increased reflexes in all extremities.
• A nontender thyroid enlargement is appreciated in the thyroid region.
• Presence of Exophthalmos
Laboratory studies
• Hematology:
• Hb: 13.9 mg/dl
• TC: 6300 (60%N,35%L,05%E) / mm3
• Platelets: 1,80,000 / mm3
• Biochemistry:
• RBS: 110 mg/dl
• Serum Urea : 4.6 mmol/L
• Serum Creatinine: 61 μmol/L
• Na+ / K+ : 144 / 5.1 mmol/L
• SGPT / SGOT : 23 / 20 U/L
• Alk Phosphatase: 40 IU/L
• Serum Calcium: 2.2 mmol/L
Special Tests:
• Iron: 70 μgm / L
• TIBC: 200 μgm / L
• Ferritin: 20 ng/ml
• Free T3 : 4.8 nmol / L ( Range: 1.8 – 2.9 nmol/L)
• Free T4 : 48.0 pmol / L (Range: 10 – 25 pmol/L)
• TSH : 0.1 mU/L (Range 0.5 – 5.0 mu/L)
Any other investigation??
• Anti TPO antibodiy
• RAIU
• TSIs
Diagnosis ??????
On further investigation..
• Thyroid Stimulating Immunoglobulins (TSIs) test is positive
• TPO antibodies are negative
Discussion:
• The patients has symptoms of nervousness, weight loss,
gastrointestinal and skin alterations, heart palpitations, heat
intolerance, and physical signs of hyperreflexia and a goiter.
• Likely diagnosis:
• Hyperthyroidism, likely Graves disease.
• Supporting points from biochemistry
• T3- High
• T4- High
• TSH – Low
• TSIs- Positive
• Biochemical mechanism:
• The most frequent cause of hyperthyroidism, Graves disease, is an
autoimmune process in which thyroid hypersecretion is caused by
circulating immunoglobulins that bind to the TSH receptor on the
thyroid follicular cells and stimulate thyroid hormone production.
• The diagnosis is confirmed by increased thyroid stimulating IgG
antibodies and is frequently seen in other family members.
• Hyperthyroidism, thyroid excess causes a tachycardia, tremor,
nervousness, thin skin, weight loss through the hypermetabolic state,
and hyperreflexia.
• If unchecked, the high levels of thyroid hormone can sometimes even
cause adrenergic crisis (so called thyroid storm), which has a high
rate of mortality.
• Normally, the thyroid hormone (thyroxine) is under tight control. The
pituitary release of thyroid stimulating hormone is stimulated by
insufficient thyroxine, and suppressed by excess thyroxine.
• In Graves disease, the most common cause of hyperthyroidism, an
autoimmune immunoglobulin is produced that stimulates the TSH
receptor of the thyroid gland.
• This is confirmed by either assaying for the Thyroid Stimulating
Immunoglobulin, or a radionuclide scan revealing diffuse increased
uptake throughout the thyroid gland.
• Treatment acutely includes β-adrenergic antagonists and agents that
inhibit the catabolism of thyroid hormone such as propylthiouracil
(PTU).
Clinical Conditions:
•Abnormal thyroid function
•Hypothyroidism
•Hyperthyroidism
Basic evaluation of thyroid disease
laboratory evaluation of thyroid function.
Hyperthyroidism:
• Increase in activities of thyroid hormones.
• Decrease in TSH due to feedback mechanism.
• Causes:
• Graves’ disease
• Toxic adenoma/hot nodule
• Multinodular goiter
• Thyroiditis(Hasitoxicosis)
• Exogenous iodine ingestion
• Excessive T3 and T4 ingestion.
• Ectopic thyroid tissue
• HCG dependent
• TSH dependent: Pituitary tumor.
Clinical Features:
• Cardiovascular:
• High thyroid hormones have a direct stimulatory effect on cardiac
muscle.
• Increase heart rate and stroke volume even at rest.
• Peripheral vascular resistance is reduced.
• Increase in cardiac output.
• Arrhythmias.
• Gastrointestinal:
• Weight loss
• Increase bowel movement.
• Liver unction can be markedly deranged, with hypoalbuminaemia and
elevation of plasma aminotransferase and alkaline phosphatase
activities.
• Nervous system:
• Generalized hyperkinesia
• Fine tremor of outstretch finger
• Loss of sleep
• Musculoskeletal:
• Weakness particularly proximal muscles.
• Due to impaired phosphorylation of creatine.
• Periodic paralysis, associated with hypokalaemia during attacks of
weakness
• Respiratory:
• Due to generalized myopathy, respiratory muscle function may be
impaired and pulmonary compliance may also be reduced.
• Dyspnoea
• Breathlessness
• Skin and hair:
• Hair loss
• Brittle nails
• Warm and moist skin.
• Skeleton
• Significant loss of mineral from the skeleton, which results from increased
bone turnover
• Hypercalciuria and hyperphosphaturia are found
• urinary hydroxyproline excretion is increased, reflecting the increase in
collagen turnover.
• Kidney:
• Increase magnesium excretion
• Increase thirst and mild polyuria even in the absence of hypercalcemia of
hyperglycemia.
• Endocrine:
• Menstrual irregularity
• Reduced fertility.
• Decrease sex steroid due to decrease binding protein.
• Gynaecomastia.
Graves’ Disease:
• Basedow-Graves disease
• Most common cause of Hyperthyroidism.
• An autoimmune disease.
• Female/Male: 6:1
• Peak onset 3rd-4th decade, but can occur at any age
• It most commonly affects the thyroid, frequently causing it to enlarge to twice its
size or more (goitre)
• It can also affect the eyes, causing bulging eyes (exophthalmos).
• It affects other systems of the body, including the skin.
Mechanism:
• Thyroid Stimulating Immunoglobulins (TSIs) bind to the TSH receptor
and mimic the action of TSH.
• Activates adenylate cyclase and the formation of cAMP.
• Genetic factor: MHC class II antigen HLA-DR3 increases risk by 3 fold
Signs and Symptoms:
• Nervousness
• Diaphoresis
• Heat intolerance
• Palpitations; tachycardia
• Insomnia
• Weight loss
• Hyper defecation
• Angina
• Atrial fibrillation
• Weakness
• Cachexia
• Graves’ opthalmopathy
• Graves’ dermopathy (pretibial
myxedema)
• Thyroid thrills or bruits
• Thyroid involvement
• Moderate enlargement of thyroid gland
• Gland is diffuse and soft in consistency
• Graves’ Opthalmopathy:
• Clinically evident in <50% of patients
• Exophthalmos
• Periorbital edema
• Extraocular muscle weakness
• Corneal ulceration
• Optic nerve damage (compression)
hyperthyroidism
Graves’ Opthalmopathy:
Symptoms
• Gritty, dry eyes
• Periorbital puffiness
• Diplopia
• Decreased vision
Graves’ Ophthalmopathy:
• Pathogenesis
• Presumed autoimmune, likely due to shared antigens on thyroid and
retroorbital tissue (possibly the TSH receptor).
• Extraocular muscles enlarge with edema, glycosaminoglycan
deposition, mononuclear cell infiltrate, and fibrosis.
hyperthyroidism
Graves’ Dermopathy(Pretibial Myxedema)
• Patients with graves disease may develop indurated purple skin.
• It is due to glycosaminoglycan deposition
• Rare, generally accompanied by eye disease
• Usually asymptomatic
• Therapy typically topical glucocorticoids
Investigations:
• TFT
• USG neck.
• Radioiodine uptake.
• Thyroid stimulating antibodies
• Anti thyroid (anti-TPO and Tg) antibodies
Findings:
• TSH low (always measure this)
• Free T4, free T3 elevated (measure one or both if TSH is low)
• Radioiodine uptake increased (excludes subacute thyroiditis and
allows Rx with radioiodine)
• Thyroid stimulating antibodies present (could measure instead of
RAIU)
• Antithyroid (anti-TPO and Tg) antibodies often present (generally
don’t measure)
hyperthyroidism
Other biochemical changes:
• High calcium level:
• Increase bone turnover.
• Low magnesium level:
• Increase excretion.
• Low LDL cholesterol:
• Increase lipolysis.
• High liver enzymes:
• Increase plasma transaminase, alkaline phosphatase
Treatment:
• Medical Therapy:
• Antithyroid drugs
• Methimazole, Propylthiouracil.
• Beta adrenergic blockers
• Iodide
• Radioiodine (I-131):
• Advantages: safe, outpatient, painless
• Disadvantages: slow, hypothyroidism, radiation
• Surgery:
• Subtotal thyroidectomy is highly effective.
• Advantages:
• Rapid (but must pre-treat with antithyroid drugs or β-blockers), may
not cause hypothyroidism
• Disadvantages:
• Inpatient surgery, general anesthesia, complications
(hypoparathyroidism, recurrent laryngeal nerve palsy)
Toxic multinodular goitre:
• Thyroid has multiple nodules, some of which may be too small to
palpate.
• Some of the nodules function autonomously.
• “Toxic” multinodular goiter signifies that the level of autonomous
function is sufficient to cause hyperthyroidism
• Shows all features of hyperthyroidism as mention earlier
• Generally the cause is not known, although some nodules have
activating mutations of the TSH receptor.
• Treat with radioiodine or surgery, as spontaneous remissions do not
occur.
hyperthyroidism
Toxic adenoma:
• Less common cause of hyperthyroidism than Graves’ disease
• In most patients, the nodule produces too little thyroid hormone to
cause hyperthyroidism
• Generally must be >2.5 cm to cause clinical hyperthyroidism (“toxic
adenoma”)
• Constitutively activating mutations of the TSH receptor are causative
in many cases
• Lab findings are similar to Graves’ disease except TSI and anti-thyroid
Abs are negative.
• Spontaneous remissions are very rare.
• Thionamides will lower T4 and T3, but will not lead to cure.
• Therefore, preferred therapy is surgery or radioiodine.
hyperthyroidism
Exogeneous Iodine ingestion
• Jod-Basedow Effect:
• Opposite of the Wolff-Chaikoff effect
• Excessive iodine loads induce hyperthyroidism
• Observed in hyperthyroid disease processes
Graves’ disease
Toxic multinodular goiter
Toxic adenoma
• This effect may lead to symptomatic thyrotoxicosis in patients who
receive large iodine doses from
Dietary changes
Contrast administration
Iodine containing medication ( Amiodarone )
Iodine containing medication ( Amiodarone )
• Amiodarone has a structure similar to that of thyroid hormones and inhibits
the peripheral conversion of T 4 to T 3 catalyzed by iodothyronine
deiodinase D1.
• Resulting concentrations of T4 may be high and T 3 low, with an increase in
rT 3.
• Thyroid stimulating hormone may rise transiently during the first few weeks
of treatment, but by four months, most patients who are euthyroid will have
normal or sometimes suppressed concentrations of TSH.
• The drug inhibits both iodine uptake by the thyroid and entry of T4 into cells
and can also cause both iodine-induced hypothyroidism and
hyperthyroidism.
Ectopic thyroid tissue.
• Metastatic thyroid follicular carcinoma may rarely produce sufficient
thyroid hormone to result in hyperthyroidism.
• Other tumors, such as ovarian teratomas, may contain functional thyroid
tissue in sufficient quantity to produce symptoms and signs of
thyrotoxicosis (struma ovarii).
• Endogenous thyroid radioisotope uptake will be suppressed and
functioning tissue demonstrable in the tumor under these most
uncommon circumstances.
HCG dependent
• Human chorionic gonadotropin (hCG)–induced hyperthyroidism is observed in
gestational transient thyrotoxicosis.
• hCG possesses intrinsic human thyroid stimulating activity
• So causes hyperthyroidism
• Usually occurs during pregnancy.
• TSH receptor sensitivity to appropriate hCG concentrations during pregnancy,
and hCG-secreting tumors.
• Gestational transient thyrotoxicosis occurs in 2 to 3% of all pregnancies, and
results from activation of TSH receptors by hCG, which is greatly elevated
during pregnancy.
• Trophoblastic tumours such as choriocarcinoma, hydatidiform mole and
metastatic embryonal testicular carcinoma may secrete human chorionic
gonadotrophin (hCG).
• The degree of hyperthyroidism is typically mild, and treatment is not usually
required.
Hashitoxicosis
• During the clinical course of Hashimoto thyroiditis, if a period of
accelerated destruction of thyroid follicular cells occurs, subsequent
release of thyroid hormone can produce a transient interval of
hyperthyroidism, termed Hashitoxicosis.
• Hashitoxicosis should be differentiated from Graves’ disease because
the treatments for these two conditions are different.
• Hashitoxicosis is self-limited
• TSIs are usually positive in patients with Graves’ disease and negative
in Hashitoxicosis.
• In addition, the RAIU is elevated in Graves’ disease but is not elevated
in Hashitoxicosis.
Postpartum Thyroiditis
• Patients with postpartum thyroiditis can experience a period of
transient, usually self-limited, hyperthyroidism from accelerated
breakdown of thyroid tissue.
• Subacute or acute thyroiditis can produce a period of transient
hyperthyroidism.
Central hyperthyroidism
• It is caused by pituitary adenomas and is rare condition
• It secrete TSH hormone excessively which causes hyperthyroidism.
• This diagnosis is suggested by
• Clinical hyperthyroidism,
• Elevated FT4
• Normal to elevated TSH concentration,
• Evidence of a pituitary mass on computed tomography (CT) scan or magnetic
resonance imaging (MRI).
• Hyperthyroidism is also caused when there is pituitary resistance to
thyroid hormone in feedback mechanism
T3 Toxicosis
• T3 toxicosis is defined by the presence of clinical hyperthyroidism in a
patient with suppressed TSH, normal FT4, and elevated T3 (or FT3).
• When a very mild excess of thyroid hormone is causing increased
thyroidal and peripheral deiodination of T4 to T3.
• D1 conversion of T4 to T3 is enhanced in hyperthyroidism.
• Raise in T3 occurs in contrast to T4
• T3 toxicosis is also possible
• when hyperthyroidism occurs in the presence of mild iodine deficiency
• when iodine is sufficient to synthesize excessive amounts of T3 but not T4.
• TSHR enhances the production of T3 more than T4.
Thyroid Storm:
• Medical Emergency
• Occurs in ~ 1% of pregnant pts with hyperthyroidism
• Thyroid storm is a decompensated state of thyroid hormone–induced,
severe hypermetabolism involving multiple systems and is the most
extreme state of thyrotoxicosis.
• The clinical picture relates to severely exaggerated effects of THs due to
increased release (with or without increased synthesis) or increased
intake of TH.
• Thyroid storm, also referred to as thyrotoxic crisis, is an acute,
• Life-threatening, hypermetabolic state induced by excessive release
of thyroid hormones (THs) in individuals with thyrotoxicosis.
• The clinical presentation includes fever, tachycardia, hypertension,
and neurological and GI abnormalities.
• Hypertension may be followed by congestive heart failure that is
associated with hypotension and shock.
•Thank you
hyperthyroidism

More Related Content

PPTX
Hypothyroidism
PPTX
Thyroid disorders
PPTX
Hypothyroidism
PPTX
Hypothyroidism
PPT
Thyroid disorders
PDF
Hypothyroidism
PPTX
SUBCLINICAL HYPOTHYROIDISM
PPTX
THYROID DISORDERS
Hypothyroidism
Thyroid disorders
Hypothyroidism
Hypothyroidism
Thyroid disorders
Hypothyroidism
SUBCLINICAL HYPOTHYROIDISM
THYROID DISORDERS

What's hot (20)

PPTX
Hyperthyroidism
PPTX
Hypothyrodism
PDF
Hypothyroidism
PPTX
Hyperthyroidism
PPTX
Hyperthyroidism
PPTX
Hypothyroidism by aina
PPTX
Hyperthyroidism
PPTX
Disorders of the Thyroid Gland
PPTX
Hypothyroidism
PPTX
Hypothyroidism
PPTX
Hypothyrodism
PPTX
Hypothyroidism
PPT
Hyperthyroidism
PPTX
management of Hyperthyroidism
PDF
Thyrotoxicosis
PPTX
Management of Thyroid Diseases & Emergencies
PPTX
Hypothyroidism
PPT
Thyroid Disorders
PPTX
congenital hypothyroidism
Hyperthyroidism
Hypothyrodism
Hypothyroidism
Hyperthyroidism
Hyperthyroidism
Hypothyroidism by aina
Hyperthyroidism
Disorders of the Thyroid Gland
Hypothyroidism
Hypothyroidism
Hypothyrodism
Hypothyroidism
Hyperthyroidism
management of Hyperthyroidism
Thyrotoxicosis
Management of Thyroid Diseases & Emergencies
Hypothyroidism
Thyroid Disorders
congenital hypothyroidism
Ad

Viewers also liked (20)

PPTX
Thyroid anatomy and pathology
PPTX
Vasoactive drugs
PPTX
Anatomy of thyroid gland cme
PPT
Acute Decompensated Heart Failure : What is New ?
PPTX
Thyroid and its pathology (Hypothyroidism).
PPTX
Shock - management
PPTX
Liver function tests and interpretation
PPTX
Upper Extremity Regional Anesthesia
PPTX
Interscalene & supraclavicular nerve blocks
PPTX
Pancreatic pseudocysts
PDF
A brief synopsis of acute decompensated heart failure
PPTX
Pseudocyst of pancreas
PPTX
Eras fast track surgery
PPTX
Eras ppt
PPT
Gallstone disease rufi
PDF
Enhanced recovery Whipps Cross
PPTX
Cervical spine and airway in trauma
PPTX
2012 Clinical Practice guidelines for hypothyroidism in adults: American Asso...
PPTX
PPTX
Damage control surgery
Thyroid anatomy and pathology
Vasoactive drugs
Anatomy of thyroid gland cme
Acute Decompensated Heart Failure : What is New ?
Thyroid and its pathology (Hypothyroidism).
Shock - management
Liver function tests and interpretation
Upper Extremity Regional Anesthesia
Interscalene & supraclavicular nerve blocks
Pancreatic pseudocysts
A brief synopsis of acute decompensated heart failure
Pseudocyst of pancreas
Eras fast track surgery
Eras ppt
Gallstone disease rufi
Enhanced recovery Whipps Cross
Cervical spine and airway in trauma
2012 Clinical Practice guidelines for hypothyroidism in adults: American Asso...
Damage control surgery
Ad

Similar to hyperthyroidism (20)

PDF
hyperthyroidisminchildren-200824025958.pdf
PPTX
Hyperthyroidism in children
PPTX
Thyroid gland dr. faeza patho
DOC
Medicine 5th year, all lectures/thyroid (Dr. Taha Mahwy)
PPTX
Thyroid gland dr faeza
PPTX
HYPERTHYROIDISM.pptx
PPTX
Thyroid disorders
PDF
thyroiddisorders-140505124709-phpapp02.pdf
PDF
Thyroid Disorders-1.pdf
PPTX
Hyperthyroidism, Thyrotoxicosis, Grave's Disease with MCQs.pptx
PPTX
Benign thyroid diseases
PPTX
Thyroid Disorders.pptx
PPTX
Hyperhypothyrodism 180220142907-1678
PPTX
hyper hypothyrodism pdf.pptx
PPTX
Hyperthyroidism and thyrotoxicosis.pptx
PDF
thyroid and parathyroid disorders
PPTX
thyroid disorders sandeep.pptxtfxgk heel Keerthi
PPTX
Hyperthyroidism
PDF
hyperthyroidism-180209201848.pdf
PPTX
Anaesthetic mgt for pt with hyperthyroidism pritam
hyperthyroidisminchildren-200824025958.pdf
Hyperthyroidism in children
Thyroid gland dr. faeza patho
Medicine 5th year, all lectures/thyroid (Dr. Taha Mahwy)
Thyroid gland dr faeza
HYPERTHYROIDISM.pptx
Thyroid disorders
thyroiddisorders-140505124709-phpapp02.pdf
Thyroid Disorders-1.pdf
Hyperthyroidism, Thyrotoxicosis, Grave's Disease with MCQs.pptx
Benign thyroid diseases
Thyroid Disorders.pptx
Hyperhypothyrodism 180220142907-1678
hyper hypothyrodism pdf.pptx
Hyperthyroidism and thyrotoxicosis.pptx
thyroid and parathyroid disorders
thyroid disorders sandeep.pptxtfxgk heel Keerthi
Hyperthyroidism
hyperthyroidism-180209201848.pdf
Anaesthetic mgt for pt with hyperthyroidism pritam

More from Deependra Shrestha (8)

PPTX
Hypothyroidism
PPTX
Thyroid gland (anatomy and physiology) biochemical basis
PPTX
Case presentation
PPTX
Disease of kidney
PPTX
Renal system
PPTX
Carbohydrates
PPTX
Carbohydrate
PPTX
Acute liver disease
Hypothyroidism
Thyroid gland (anatomy and physiology) biochemical basis
Case presentation
Disease of kidney
Renal system
Carbohydrates
Carbohydrate
Acute liver disease

Recently uploaded (20)

PPTX
Journal Article Review - Ankolysing Spondylitis - Dr Manasa.pptx
PPTX
presentation on dengue and its management
PPTX
Local Anesthesia Local Anesthesia Local Anesthesia
PDF
495958952-Techno-Obstetric-sminiOSCE.pdf
PPTX
Assessment of fetal wellbeing for nurses.
PPTX
SEMINAR 6 DRUGS .pptxgeneral pharmacology
PPTX
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
PPTX
Introduction to CDC (1).pptx for health science students
PPT
intrduction to nephrologDDDDDDDDDy lec1.ppt
PPTX
Hypertensive disorders in pregnancy.pptx
PPTX
Genetics and health: study of genes and their roles in inheritance
PPTX
AWMI case presentation ppt AWMI case presentation ppt
PDF
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in an...
PPTX
This book is about some common childhood
PPTX
Tuberculosis : NTEP and recent updates (2024)
PPTX
Pharynx and larynx -4.............pptx
PPTX
ACUTE PANCREATITIS combined.pptx.pptx in kids
PPTX
abgs and brain death dr js chinganga.pptx
PDF
NCM-107-LEC-REVIEWER.pdf 555555555555555
PDF
Tackling Intensified Climatic Civil and Meteorological Aviation Weather Chall...
Journal Article Review - Ankolysing Spondylitis - Dr Manasa.pptx
presentation on dengue and its management
Local Anesthesia Local Anesthesia Local Anesthesia
495958952-Techno-Obstetric-sminiOSCE.pdf
Assessment of fetal wellbeing for nurses.
SEMINAR 6 DRUGS .pptxgeneral pharmacology
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
Introduction to CDC (1).pptx for health science students
intrduction to nephrologDDDDDDDDDy lec1.ppt
Hypertensive disorders in pregnancy.pptx
Genetics and health: study of genes and their roles in inheritance
AWMI case presentation ppt AWMI case presentation ppt
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in an...
This book is about some common childhood
Tuberculosis : NTEP and recent updates (2024)
Pharynx and larynx -4.............pptx
ACUTE PANCREATITIS combined.pptx.pptx in kids
abgs and brain death dr js chinganga.pptx
NCM-107-LEC-REVIEWER.pdf 555555555555555
Tackling Intensified Climatic Civil and Meteorological Aviation Weather Chall...

hyperthyroidism

  • 2. Clinical Scenario • A 39-year-old female presents to the clinic for a routine health maintenance exam. • She reports that she is feeling nervous and anxious all the time with frequent palpitations. • On further questioning she reports having diarrhea and has been losing weight. • She has also noticed a change in hair and fingernail growth and frequently feels warm while others are cold or comfortable. • She denies any history of depression or anxiety disorder and is not taking any medications. • On examination, her heart rate is 110 beats per minute. She has a slight tremor and has increased reflexes in all extremities. • A nontender thyroid enlargement is appreciated in the thyroid region. • Presence of Exophthalmos
  • 3. Laboratory studies • Hematology: • Hb: 13.9 mg/dl • TC: 6300 (60%N,35%L,05%E) / mm3 • Platelets: 1,80,000 / mm3 • Biochemistry: • RBS: 110 mg/dl • Serum Urea : 4.6 mmol/L • Serum Creatinine: 61 μmol/L • Na+ / K+ : 144 / 5.1 mmol/L • SGPT / SGOT : 23 / 20 U/L • Alk Phosphatase: 40 IU/L • Serum Calcium: 2.2 mmol/L
  • 4. Special Tests: • Iron: 70 μgm / L • TIBC: 200 μgm / L • Ferritin: 20 ng/ml • Free T3 : 4.8 nmol / L ( Range: 1.8 – 2.9 nmol/L) • Free T4 : 48.0 pmol / L (Range: 10 – 25 pmol/L) • TSH : 0.1 mU/L (Range 0.5 – 5.0 mu/L)
  • 5. Any other investigation?? • Anti TPO antibodiy • RAIU • TSIs
  • 7. On further investigation.. • Thyroid Stimulating Immunoglobulins (TSIs) test is positive • TPO antibodies are negative
  • 8. Discussion: • The patients has symptoms of nervousness, weight loss, gastrointestinal and skin alterations, heart palpitations, heat intolerance, and physical signs of hyperreflexia and a goiter. • Likely diagnosis: • Hyperthyroidism, likely Graves disease. • Supporting points from biochemistry • T3- High • T4- High • TSH – Low • TSIs- Positive
  • 9. • Biochemical mechanism: • The most frequent cause of hyperthyroidism, Graves disease, is an autoimmune process in which thyroid hypersecretion is caused by circulating immunoglobulins that bind to the TSH receptor on the thyroid follicular cells and stimulate thyroid hormone production. • The diagnosis is confirmed by increased thyroid stimulating IgG antibodies and is frequently seen in other family members. • Hyperthyroidism, thyroid excess causes a tachycardia, tremor, nervousness, thin skin, weight loss through the hypermetabolic state, and hyperreflexia. • If unchecked, the high levels of thyroid hormone can sometimes even cause adrenergic crisis (so called thyroid storm), which has a high rate of mortality.
  • 10. • Normally, the thyroid hormone (thyroxine) is under tight control. The pituitary release of thyroid stimulating hormone is stimulated by insufficient thyroxine, and suppressed by excess thyroxine. • In Graves disease, the most common cause of hyperthyroidism, an autoimmune immunoglobulin is produced that stimulates the TSH receptor of the thyroid gland. • This is confirmed by either assaying for the Thyroid Stimulating Immunoglobulin, or a radionuclide scan revealing diffuse increased uptake throughout the thyroid gland. • Treatment acutely includes β-adrenergic antagonists and agents that inhibit the catabolism of thyroid hormone such as propylthiouracil (PTU).
  • 11. Clinical Conditions: •Abnormal thyroid function •Hypothyroidism •Hyperthyroidism
  • 12. Basic evaluation of thyroid disease
  • 13. laboratory evaluation of thyroid function.
  • 14. Hyperthyroidism: • Increase in activities of thyroid hormones. • Decrease in TSH due to feedback mechanism. • Causes: • Graves’ disease • Toxic adenoma/hot nodule • Multinodular goiter • Thyroiditis(Hasitoxicosis) • Exogenous iodine ingestion • Excessive T3 and T4 ingestion. • Ectopic thyroid tissue • HCG dependent • TSH dependent: Pituitary tumor.
  • 15. Clinical Features: • Cardiovascular: • High thyroid hormones have a direct stimulatory effect on cardiac muscle. • Increase heart rate and stroke volume even at rest. • Peripheral vascular resistance is reduced. • Increase in cardiac output. • Arrhythmias. • Gastrointestinal: • Weight loss • Increase bowel movement. • Liver unction can be markedly deranged, with hypoalbuminaemia and elevation of plasma aminotransferase and alkaline phosphatase activities.
  • 16. • Nervous system: • Generalized hyperkinesia • Fine tremor of outstretch finger • Loss of sleep • Musculoskeletal: • Weakness particularly proximal muscles. • Due to impaired phosphorylation of creatine. • Periodic paralysis, associated with hypokalaemia during attacks of weakness
  • 17. • Respiratory: • Due to generalized myopathy, respiratory muscle function may be impaired and pulmonary compliance may also be reduced. • Dyspnoea • Breathlessness • Skin and hair: • Hair loss • Brittle nails • Warm and moist skin.
  • 18. • Skeleton • Significant loss of mineral from the skeleton, which results from increased bone turnover • Hypercalciuria and hyperphosphaturia are found • urinary hydroxyproline excretion is increased, reflecting the increase in collagen turnover. • Kidney: • Increase magnesium excretion • Increase thirst and mild polyuria even in the absence of hypercalcemia of hyperglycemia. • Endocrine: • Menstrual irregularity • Reduced fertility. • Decrease sex steroid due to decrease binding protein. • Gynaecomastia.
  • 19. Graves’ Disease: • Basedow-Graves disease • Most common cause of Hyperthyroidism. • An autoimmune disease. • Female/Male: 6:1 • Peak onset 3rd-4th decade, but can occur at any age • It most commonly affects the thyroid, frequently causing it to enlarge to twice its size or more (goitre) • It can also affect the eyes, causing bulging eyes (exophthalmos). • It affects other systems of the body, including the skin.
  • 20. Mechanism: • Thyroid Stimulating Immunoglobulins (TSIs) bind to the TSH receptor and mimic the action of TSH. • Activates adenylate cyclase and the formation of cAMP. • Genetic factor: MHC class II antigen HLA-DR3 increases risk by 3 fold
  • 21. Signs and Symptoms: • Nervousness • Diaphoresis • Heat intolerance • Palpitations; tachycardia • Insomnia • Weight loss • Hyper defecation • Angina • Atrial fibrillation • Weakness • Cachexia • Graves’ opthalmopathy • Graves’ dermopathy (pretibial myxedema) • Thyroid thrills or bruits
  • 22. • Thyroid involvement • Moderate enlargement of thyroid gland • Gland is diffuse and soft in consistency • Graves’ Opthalmopathy: • Clinically evident in <50% of patients • Exophthalmos • Periorbital edema • Extraocular muscle weakness • Corneal ulceration • Optic nerve damage (compression)
  • 24. Graves’ Opthalmopathy: Symptoms • Gritty, dry eyes • Periorbital puffiness • Diplopia • Decreased vision
  • 25. Graves’ Ophthalmopathy: • Pathogenesis • Presumed autoimmune, likely due to shared antigens on thyroid and retroorbital tissue (possibly the TSH receptor). • Extraocular muscles enlarge with edema, glycosaminoglycan deposition, mononuclear cell infiltrate, and fibrosis.
  • 27. Graves’ Dermopathy(Pretibial Myxedema) • Patients with graves disease may develop indurated purple skin. • It is due to glycosaminoglycan deposition • Rare, generally accompanied by eye disease • Usually asymptomatic • Therapy typically topical glucocorticoids
  • 28. Investigations: • TFT • USG neck. • Radioiodine uptake. • Thyroid stimulating antibodies • Anti thyroid (anti-TPO and Tg) antibodies
  • 29. Findings: • TSH low (always measure this) • Free T4, free T3 elevated (measure one or both if TSH is low) • Radioiodine uptake increased (excludes subacute thyroiditis and allows Rx with radioiodine) • Thyroid stimulating antibodies present (could measure instead of RAIU) • Antithyroid (anti-TPO and Tg) antibodies often present (generally don’t measure)
  • 31. Other biochemical changes: • High calcium level: • Increase bone turnover. • Low magnesium level: • Increase excretion. • Low LDL cholesterol: • Increase lipolysis. • High liver enzymes: • Increase plasma transaminase, alkaline phosphatase
  • 32. Treatment: • Medical Therapy: • Antithyroid drugs • Methimazole, Propylthiouracil. • Beta adrenergic blockers • Iodide • Radioiodine (I-131): • Advantages: safe, outpatient, painless • Disadvantages: slow, hypothyroidism, radiation
  • 33. • Surgery: • Subtotal thyroidectomy is highly effective. • Advantages: • Rapid (but must pre-treat with antithyroid drugs or β-blockers), may not cause hypothyroidism • Disadvantages: • Inpatient surgery, general anesthesia, complications (hypoparathyroidism, recurrent laryngeal nerve palsy)
  • 34. Toxic multinodular goitre: • Thyroid has multiple nodules, some of which may be too small to palpate. • Some of the nodules function autonomously. • “Toxic” multinodular goiter signifies that the level of autonomous function is sufficient to cause hyperthyroidism
  • 35. • Shows all features of hyperthyroidism as mention earlier • Generally the cause is not known, although some nodules have activating mutations of the TSH receptor. • Treat with radioiodine or surgery, as spontaneous remissions do not occur.
  • 37. Toxic adenoma: • Less common cause of hyperthyroidism than Graves’ disease • In most patients, the nodule produces too little thyroid hormone to cause hyperthyroidism • Generally must be >2.5 cm to cause clinical hyperthyroidism (“toxic adenoma”) • Constitutively activating mutations of the TSH receptor are causative in many cases
  • 38. • Lab findings are similar to Graves’ disease except TSI and anti-thyroid Abs are negative. • Spontaneous remissions are very rare. • Thionamides will lower T4 and T3, but will not lead to cure. • Therefore, preferred therapy is surgery or radioiodine.
  • 40. Exogeneous Iodine ingestion • Jod-Basedow Effect: • Opposite of the Wolff-Chaikoff effect • Excessive iodine loads induce hyperthyroidism • Observed in hyperthyroid disease processes Graves’ disease Toxic multinodular goiter Toxic adenoma • This effect may lead to symptomatic thyrotoxicosis in patients who receive large iodine doses from Dietary changes Contrast administration Iodine containing medication ( Amiodarone )
  • 41. Iodine containing medication ( Amiodarone ) • Amiodarone has a structure similar to that of thyroid hormones and inhibits the peripheral conversion of T 4 to T 3 catalyzed by iodothyronine deiodinase D1. • Resulting concentrations of T4 may be high and T 3 low, with an increase in rT 3. • Thyroid stimulating hormone may rise transiently during the first few weeks of treatment, but by four months, most patients who are euthyroid will have normal or sometimes suppressed concentrations of TSH. • The drug inhibits both iodine uptake by the thyroid and entry of T4 into cells and can also cause both iodine-induced hypothyroidism and hyperthyroidism.
  • 42. Ectopic thyroid tissue. • Metastatic thyroid follicular carcinoma may rarely produce sufficient thyroid hormone to result in hyperthyroidism. • Other tumors, such as ovarian teratomas, may contain functional thyroid tissue in sufficient quantity to produce symptoms and signs of thyrotoxicosis (struma ovarii). • Endogenous thyroid radioisotope uptake will be suppressed and functioning tissue demonstrable in the tumor under these most uncommon circumstances.
  • 43. HCG dependent • Human chorionic gonadotropin (hCG)–induced hyperthyroidism is observed in gestational transient thyrotoxicosis. • hCG possesses intrinsic human thyroid stimulating activity • So causes hyperthyroidism • Usually occurs during pregnancy. • TSH receptor sensitivity to appropriate hCG concentrations during pregnancy, and hCG-secreting tumors. • Gestational transient thyrotoxicosis occurs in 2 to 3% of all pregnancies, and results from activation of TSH receptors by hCG, which is greatly elevated during pregnancy. • Trophoblastic tumours such as choriocarcinoma, hydatidiform mole and metastatic embryonal testicular carcinoma may secrete human chorionic gonadotrophin (hCG). • The degree of hyperthyroidism is typically mild, and treatment is not usually required.
  • 44. Hashitoxicosis • During the clinical course of Hashimoto thyroiditis, if a period of accelerated destruction of thyroid follicular cells occurs, subsequent release of thyroid hormone can produce a transient interval of hyperthyroidism, termed Hashitoxicosis. • Hashitoxicosis should be differentiated from Graves’ disease because the treatments for these two conditions are different. • Hashitoxicosis is self-limited • TSIs are usually positive in patients with Graves’ disease and negative in Hashitoxicosis. • In addition, the RAIU is elevated in Graves’ disease but is not elevated in Hashitoxicosis.
  • 45. Postpartum Thyroiditis • Patients with postpartum thyroiditis can experience a period of transient, usually self-limited, hyperthyroidism from accelerated breakdown of thyroid tissue. • Subacute or acute thyroiditis can produce a period of transient hyperthyroidism.
  • 46. Central hyperthyroidism • It is caused by pituitary adenomas and is rare condition • It secrete TSH hormone excessively which causes hyperthyroidism. • This diagnosis is suggested by • Clinical hyperthyroidism, • Elevated FT4 • Normal to elevated TSH concentration, • Evidence of a pituitary mass on computed tomography (CT) scan or magnetic resonance imaging (MRI). • Hyperthyroidism is also caused when there is pituitary resistance to thyroid hormone in feedback mechanism
  • 47. T3 Toxicosis • T3 toxicosis is defined by the presence of clinical hyperthyroidism in a patient with suppressed TSH, normal FT4, and elevated T3 (or FT3). • When a very mild excess of thyroid hormone is causing increased thyroidal and peripheral deiodination of T4 to T3. • D1 conversion of T4 to T3 is enhanced in hyperthyroidism. • Raise in T3 occurs in contrast to T4 • T3 toxicosis is also possible • when hyperthyroidism occurs in the presence of mild iodine deficiency • when iodine is sufficient to synthesize excessive amounts of T3 but not T4. • TSHR enhances the production of T3 more than T4.
  • 48. Thyroid Storm: • Medical Emergency • Occurs in ~ 1% of pregnant pts with hyperthyroidism • Thyroid storm is a decompensated state of thyroid hormone–induced, severe hypermetabolism involving multiple systems and is the most extreme state of thyrotoxicosis. • The clinical picture relates to severely exaggerated effects of THs due to increased release (with or without increased synthesis) or increased intake of TH. • Thyroid storm, also referred to as thyrotoxic crisis, is an acute,
  • 49. • Life-threatening, hypermetabolic state induced by excessive release of thyroid hormones (THs) in individuals with thyrotoxicosis. • The clinical presentation includes fever, tachycardia, hypertension, and neurological and GI abnormalities. • Hypertension may be followed by congestive heart failure that is associated with hypotension and shock.

Editor's Notes

  • #13: Familial dysalbuminemic hyperthyroxinemia